Supply Chain

Apiject announced today that it signed a lease on a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina. The injection delivery system developer plans for the new facility to house two advanced blow-fill-seal (BFS) production lines and serve as an outsourcing facility focused on producing essential generic injectable medicines currently on the FDA’s drug shortage…

BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, Nebraska. Franklin Lakes, New Jersey-based BD aims to expand prefillable syringe production to accelerate biologic and GLP-1 drug delivery and support pharmaceutical reshoring in the U.S. The investment brings the company’s Neopak glass prefillable syringe production to…

Samsung Biologics announced today that it agreed to acquire 100% of Human Genome Sciences from GSK. The acquisition secures Samsung Biologics’ first U.S.-based manufacturing site, located in Rockville, Maryland. It helps to expand the company’s global footprint and commitment to the U.S. market following its transition to become a pure-play CDMO. GSK’s Rockville facility encompasses…

Novartis announced today that it broke ground on its more than 700,000-square-foot flagship manufacturing hub in North Carolina. The company said it is rapidly moving to construct its recently announced $771 million investment in the state. Its project features a new facility in Morrisville and a new site in Durham, encompassing two new facilities. The…

AstraZeneca announced today that it plans to invest $2 billion to expand its pharmaceutical manufacturing footprint in Maryland. The company plans to expand its flagship biologics manufacturing facility and construct a new state-of-the-art facility in Gaithersburg. It plans for the facilities to aid in the development and clinical supply of innovative molecules for use in…

Novartis announced today that it opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in California. The state-of-the-art site in Carlsbad marks the latest milestone in the company’s previously announced $23 billion investment in U.S. infrastructure over the next five years. Novartis says the Carlsbad facility opening allows it to seamlessly meet future demand for…

Samsung Biologics announced today that it completed the spinoff of its Samsung Bioepis unit to focus on leading as a pure-play CDMO. Following approval from its board, Samsung Biologics separated its investment and subsidiary management business to establish Samsung Epis Holdings. It finalized its Decision on Nov. 1 with plans to proceed with registration for…

Eli Lilly (NYSE:LLY) announced today that it plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands. Located within the Leiden Bio Science Park, the new project aims to expand Lilly’s capacity to produce oral medicines. The company also hopes to strengthen its global supply chain with the new plant. Indianapolis-based Lilly…

Trelleborg has announced the grand opening of its expanded manufacturing facility and BioPharma Center of Excellence in Northborough, Massachusetts. The new facility for the Plymouth, Massachusetts-based company drives its strategy for growth in the biopharmaceutical industry. “Our expanded BioPharma Center of Excellence supports our goal of being the partner of choice for all leading biopharmaceutical…

Eli Lilly (NYSE:LLY) announced today that it plans to invest more than $1.2 billion to expand and modernize a manufacturing site in Puerto Rico. The company plans to integrate advanced technologies and expand production capacity within the existing campus at its Lilly del Caribe plant in Carolina, Puerto Rico. It hopes to support its growing…